Daewoong Pharmaceutical Rises 3.5% Amid COVID-19 (Camostat) Theme Uptrend

On the 22nd, the COVID-19 (Camostat) theme rose by 3.40% compared to the previous day, showing a strong performance, while Daewoong Pharmaceutical, which is attracting attention as a related stock, surged by 3.5% compared to the previous day. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling drugs such as Urusa and Albis.

[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong Pharmaceutical ranked 2nd out of 4 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Daewoong Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial scores are the results of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.